BPC-157

META-TITLE: [TODO: BPC-157 — Healing Peptide Research Profile | Brand]
META-DESC: [TODO: Comprehensive BPC-157 research profile — gastric pentadecapeptide mechanism, tissue repair studies, dosing, safety.]

[TODO] Hook — BPC-157 as the most researched healing peptide, gastric juice-derived, broad tissue repair potential across 100+ studies

[IMAGE: BPC-157 molecular structure — 15 amino acid sequence visualization]

What is BPC-157?

  • [TODO] Full name — Body Protection Compound-157, pentadecapeptide (15 amino acids)
  • [TODO] Origin — isolated from human gastric juice, part of larger BPC protein
  • [TODO] Molecular weight — 1419.53 Da
  • [TODO] Stability — stable in gastric acid (unique for peptides), no carrier needed
  • [TODO] Research scope — 100+ published studies, mostly animal models

Mechanism of Action

[IMAGE: Diagram of BPC-157 pathways — NO system, VEGF, FAK-paxillin, GH receptor interaction]
  • [TODO] Nitric oxide system — modulates eNOS, promotes vasodilation and blood flow to injured tissue
  • [TODO] Angiogenesis — VEGF upregulation, new blood vessel formation in damaged areas
  • [TODO] FAK-paxillin pathway — cell migration and tissue repair signaling
  • [TODO] Growth hormone receptor interaction — upregulates GH receptor expression
  • [TODO] Anti-inflammatory — reduces TNF-alpha, modulates cytokine profile
  • [TODO] GI protection — cytoprotective in gastric/intestinal mucosa

Research Highlights

  • [TODO] Tendon/ligament — accelerated healing in Achilles tendon transection (rat)
  • [TODO] Muscle — improved recovery after crush injury, laceration models
  • [TODO] GI tract — gastric ulcer healing, IBD models, fistula repair
  • [TODO] Bone — enhanced fracture healing, osteogenic activity
  • [TODO] Neuroprotection — peripheral nerve repair, dopaminergic system interaction
  • [TODO] Limitation — no completed human clinical trials to date

Dosing Protocols (Research Context)

  • [TODO] Typical research dose — 200-800mcg/day (subcutaneous or oral)
  • [TODO] Systemic vs local — SC near injury site vs systemic injection vs oral
  • [TODO] Duration — 4-6 week protocols common in animal literature
  • [TODO] Reconstitution — bacteriostatic water, store 2-8°C, use within 4 weeks

Safety & Considerations

  • [TODO] Toxicity data — no reported LD50, no organ toxicity in animal studies
  • [TODO] Side effects — minimal reported in animal literature
  • [TODO] Limitations — predominantly animal data, lack of human RCTs
  • [TODO] WADA status — listed on prohibited substance list (S0 category)

Frequently Asked Questions

[FAQ: Can BPC-157 be taken orally or is injection required?]
[FAQ: How does BPC-157 compare to TB-500 for tissue repair?]
[FAQ: What is the shelf life after reconstitution?]
[FAQ: Are there any human clinical trials for BPC-157?]
[FAQ: Does BPC-157 interact with other peptides?]

Related Products

[TODO] Link to BPC-157 product page + Healing & Recovery category

Continue Reading

All Articles